Samuel Rivero-Hinojosa

10PUBLICATIONS
55CO-AUTHORS
Central nervous systemPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 14, 2026
Longitudinal Detection of Tumor-Specific Peptides in Cerebrospinal Fluid for Pediatric Brain Tumor Surveillance.

Kelsi M Chesney, Jeffrey R Whiteaker, Brian Hood

|Feb 26, 2026
Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma.

Paul B Romesser, Aron Bercz, Janet Alvarez

|Dec 09, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors.

Mark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf

|Jan 31, 2024
BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites.

Elena M Pugacheva, Dharmendra Nath Bhatt, Samuel Rivero-Hinojosa

|Mar 29, 2023
A Therapeutic Vaccine Targeting Rat BORIS (CTCFL) for the Treatment of Rat Breast Cancer Tumors.

Dmitri Loukinov, Amanda Laust Anderson, Mikayel Mkrtichyan

|Jun 23, 2022
OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma.

Zhenhua Xu, Najiba Murad, Daniel Malawsky

Pageof 2

Frequent Collaborators

3 joint publications

Victor V Lobanenkov

2 joint publications

Elena M Pugacheva

2 joint publications

Minetta C Liu

1 joint publications

Yingchao Xue